Gene Expression Nebulas
A data portal of transcriptomic profiles analyzed by a unified pipeline across multiple species

Gene Expression Nebulas

A data portal of transcriptome profiles across multiple species

PRJNA505801: RORγt inhibition selectively targets IL-17 producing human iNKT and γδ-T cells enriched in Spondyloarthritis while preserving IL-22 responses

Source: NCBI / GSE122624
Submission Date: Nov 16 2018
Release Date: Nov 17 2018
Update Date: Nov 17 2018

Summary: Dysregulated IL-23/IL-17 responses have been linked to psoriatic arthritis and other forms of spondyloarthritides (SpA). RORγt, the key Thelper17 (Th17) cell transcriptional regulator, is also expressed by subsets of innate-like T cells, including invariant natural killer T (iNKT) and γδ-T cells, but how they contribute to disorders such as SpA is still unclear. Here we describe the presence of particular RORγt+T-betloPLZF- iNKT and γδ-hi T cell subsets in healthy peripheral blood. RORγt+ iNKT and γδ-hi T cells showed profound IL-23 mediated Th17-like immune responses and were clearly enriched within inflamed joints of SpA patients where they act as major IL-17 secretors. SpA derived iNKT and γδ-T cells showed a unique Th17 skewed phenotype and gene expression profile. Strikingly, RORγt inhibition blocked γδ17 and iNKT17 cell function while selectively sparing IL-22+ subsets. Overall, these findings highlight a unique diversity of human RORγt+ T cells and underscore the potential of RORγt antagonism to modulate aberrant type 17 responses.

Overall Design: iNKT (CD3+TCRVb11+6B11+), γδ-T (CD3+TCRγδ+) cells and Tconv (CD3+CD161-; negative for iNKT and γδ-T markers) cells were sorted from peripheral blood samples of SpA patients (n=7) and RA patients (n=5). Sequence-libraries of each sample were sequenced on a NextSeq500 system (Illumina).

GEN Datasets:
GEND000026
Strategy:
Species:
Tissue:
Healthy Condition:
Cell Type:
Protocol
Growth Protocol: For iNKT assays, PBMC were cultured in 24-well plates (1.5 × 106 cell/well) for 14days in the presence of αGalCer (100 ng/mL, in house made) and IL-23 (20 ng/mL), IL-1β (10 ng/mL), TGFβ1 (5 ng/mL; all eBioscience), and IL-2 (5 U/mL, Roche) or IL-2 alone. Similar experiments were performed with sorted iNKT and γδ-T cell in U bottom 96 well plates (50,000 cell/well) where we added 50,000 irradiated (40 Gy) T cell depleted PBMC cell (using CD2 dynabeads, ThermoFisher) as feeder/antigen presenting cell. Cytokine titers in supernatants were then determined by ELISA (ebioscience) or multiplex protein assays (MSD).; -
Treatment Protocol: Patients were treatment naïve or under treatment with a NSAID and/or DMARD (Methotrexate, Sulfasalazin)
Extract Protocol: RNA was isolated by means of the RNeasy Micro kit following manufacturer’s instructions (Qiagen).
Library Construction Protocol: From the sheared material, sequencing libraries were prepared with the NEBNext Ultra DNA Library Prep Kit for Illumina (version 6.0–2/18), according to the manufacturer’s protocol including a size selection to 250bp insert size.
Sequencing
Molecule Type: poly(A)+ RNA
Library Source:
Library Layout: SINGLE
Library Strand: -
Platform: ILLUMINA
Instrument Model: Illumina NextSeq 500
Strand-Specific: Unspecific
Samples
Basic Information:
Sample Characteristic:
Biological Condition:
Experimental Variables:
Protocol:
Sequencing:
Assessing Quality:
Analysis:
Data Resource GEN Sample ID GEN Dataset ID Project ID BioProject ID Sample ID Sample Name BioSample ID Sample Accession Experiment Accession Release Date Submission Date Update Date Species Race Ethnicity Age Age Unit Gender Source Name Tissue Cell Type Cell Subtype Cell Line Disease Disease State Development Stage Mutation Phenotype Case Detail Control Detail Growth Protocol Treatment Protocol Extract Protocol Library Construction Protocol Molecule Type Library Layout Strand-Specific Library Strand Spike-In Strategy Platform Instrument Model Cell Number Reads Number Gbases AvgSpotLen1 AvgSpotLen2 Uniq Mapping Rate Multiple Mapping Rate Coverage Rate
Publications
RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients.
Nature communications . 2019-01-02 [PMID: 30602780]